Carson Wealth (CWM LLC)
MRSN

Carson Wealth (CWM LLC)’s Mersana Therapeutics MRSN Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,286
Closed -$66K – 5754
2025
Q4 		$66K Sell
2,286
-3,470
-60% -$65.9K ﹤0.01% 3400
2025
Q3 		$44K Sell
5,756
-860
-13% -$6.45K ﹤0.01% 3634
2025
Q2 		$49K Sell
6,616
-777
-11% -$6.83K ﹤0.01% 3297
2025
Q1 		$64K Buy
7,393
+7,386
+105,514% +$114K ﹤0.01% 2769
2024
Q4 		$0 Buy
7
+2
+40% +$103 ﹤0.01% 5061
2024
Q3 		$0 Buy
5
+3
+150% +$132 ﹤0.01% 5025
2024
Q2 		$0 Buy
+2
New +$145 ﹤0.01% 4802
2024
Q1 		– Hold
0
– – – 4578
2022
Q1 		– Sell
-4
Closed -$1K – 3742
2021
Q4 		$1K Buy
+4
New +$778 ﹤0.01% 3340

Other funds holding MRSN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Carson Wealth (CWM LLC)'s MRSN Position: Q1 2026 in Review

Carson Wealth (CWM LLC) sold out of Mersana Therapeutics (MRSN) in Q1 2026, closing a stake of 2,286 shares — an estimated $66K sold.

Carson Wealth (CWM LLC) first reported a position in MRSN in Q4 2021 and held it in 8 quarters. The position peaked at $66K in Q4 2025. 1 fund tracked by Wall St. Rank holds MRSN as of Q1 2026.

  • Carson Wealth (CWM LLC) reported no remaining Mersana Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 2,286 Mersana Therapeutics shares in Q1 2026, an estimated $66K.
  • Carson Wealth (CWM LLC) first reported a position in Mersana Therapeutics in Q4 2021 and held it in 8 quarters.
  • Carson Wealth (CWM LLC)'s Mersana Therapeutics position peaked at $66K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.